Oramed Pharm's market cap is currently $110.71M. The company's EPS TTM is $-0.476; its P/E ratio is 21.10; Oramed Pharm is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
